IL145885A0 - Membrane disruptive peptides covalently oligomerized - Google Patents

Membrane disruptive peptides covalently oligomerized

Info

Publication number
IL145885A0
IL145885A0 IL14588500A IL14588500A IL145885A0 IL 145885 A0 IL145885 A0 IL 145885A0 IL 14588500 A IL14588500 A IL 14588500A IL 14588500 A IL14588500 A IL 14588500A IL 145885 A0 IL145885 A0 IL 145885A0
Authority
IL
Israel
Prior art keywords
oligomerized
membrane disruptive
peptides covalently
disruptive peptides
covalently
Prior art date
Application number
IL14588500A
Other languages
English (en)
Original Assignee
Cobra Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909567.1A external-priority patent/GB9909567D0/en
Priority claimed from GBGB9916912.0A external-priority patent/GB9916912D0/en
Priority claimed from GBGB9928303.8A external-priority patent/GB9928303D0/en
Application filed by Cobra Therapeutics Ltd filed Critical Cobra Therapeutics Ltd
Publication of IL145885A0 publication Critical patent/IL145885A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL14588500A 1999-04-26 2000-04-25 Membrane disruptive peptides covalently oligomerized IL145885A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9909567.1A GB9909567D0 (en) 1999-04-26 1999-04-26 A modified membrane disruptive peptide
US13237699P 1999-05-04 1999-05-04
GBGB9916912.0A GB9916912D0 (en) 1999-07-19 1999-07-19 A modified membrane disruptive peptide
GBGB9928303.8A GB9928303D0 (en) 1999-11-30 1999-11-30 A modified membrane disruptive peptide
PCT/GB2000/001588 WO2000064929A1 (en) 1999-04-26 2000-04-25 Membrane disruptive peptides covalently oligomerized

Publications (1)

Publication Number Publication Date
IL145885A0 true IL145885A0 (en) 2002-07-25

Family

ID=27451899

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14588500A IL145885A0 (en) 1999-04-26 2000-04-25 Membrane disruptive peptides covalently oligomerized

Country Status (9)

Country Link
EP (1) EP1173474A1 (zh)
JP (1) JP2002544126A (zh)
KR (1) KR20020007382A (zh)
CN (1) CN1349543A (zh)
AU (1) AU4584800A (zh)
CA (1) CA2370284A1 (zh)
HK (1) HK1044003A1 (zh)
IL (1) IL145885A0 (zh)
WO (1) WO2000064929A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
CN106589102A (zh) * 2016-11-30 2017-04-26 青岛大学 Orexin‑A聚乙二醇化修饰物制备及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010692C2 (nl) * 1998-12-01 2000-06-06 Stichting Tech Wetenschapp Antivirale peptiden.

Also Published As

Publication number Publication date
CN1349543A (zh) 2002-05-15
JP2002544126A (ja) 2002-12-24
AU4584800A (en) 2000-11-10
KR20020007382A (ko) 2002-01-26
HK1044003A1 (zh) 2002-10-04
EP1173474A1 (en) 2002-01-23
CA2370284A1 (en) 2000-11-02
WO2000064929A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
AU6906800A (en) Membrane associated proteins
AU7358700A (en) Dolastatin peptides
GB9912852D0 (en) Peptides
EP1173467A4 (en) CHEMOKIN DERIVED SYNTHETIC PEPTIDES
GB9921125D0 (en) Proteins
AU6223700A (en) Gtp-binding associated proteins
GB9918156D0 (en) Synthetic peptides
EP1147130A4 (en) ALPHA-CONOTOXIN PEPTIDES
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
IL145885A0 (en) Membrane disruptive peptides covalently oligomerized
GB9904695D0 (en) Peptide
GB0120713D0 (en) Peptides
AU3506800A (en) Leukocyte- and blood-associated proteins
AU3774000A (en) Conformationally constrained peptides
GB9908920D0 (en) Peptide
EP1151100A4 (en) PEPTIDES DESIGNED TAU-CONOTOXINS
HK1045173A1 (zh) 多肽
GB0202889D0 (en) Peptides (assay)
GB9928303D0 (en) A modified membrane disruptive peptide
GB9916912D0 (en) A modified membrane disruptive peptide
GB9909567D0 (en) A modified membrane disruptive peptide
GB9907911D0 (en) Peptides
GB9928325D0 (en) Peptides
GB9918680D0 (en) Polypeptide
AUPQ305799A0 (en) Peptides